Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesChange in Working CapitalExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVSEF) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to -$981.0 million.

  • Novartis Ag's Gains from Investment Securities fell 616.88% to -$981.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.6 billion, marking a year-over-year decrease of 1346.32%. This contributed to the annual value of -$2.6 billion for FY2025, which is 1346.32% down from last year.
  • According to the latest figures from Q4 2025, Novartis Ag's Gains from Investment Securities is -$981.0 million, which was down 616.88% from -$366.0 million recorded in Q3 2025.
  • Novartis Ag's 5-year Gains from Investment Securities high stood at -$260.0 million for Q3 2022, and its period low was -$1.1 billion during Q4 2023.
  • Moreover, its 5-year median value for Gains from Investment Securities was -$558.0 million (2024), whereas its average is -$589.1 million.
  • Per our database at Business Quant, Novartis Ag's Gains from Investment Securities soared by 6217.44% in 2022 and then plummeted by 22724.55% in 2023.
  • Quarter analysis of 5 years shows Novartis Ag's Gains from Investment Securities stood at -$883.0 million in 2021, then surged by 62.17% to -$334.0 million in 2022, then tumbled by 227.25% to -$1.1 billion in 2023, then rose by 15.46% to -$924.0 million in 2024, then dropped by 6.17% to -$981.0 million in 2025.
  • Its last three reported values are -$981.0 million in Q4 2025, -$366.0 million for Q3 2025, and -$675.0 million during Q2 2025.